First Pacific Financial’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.01M Sell
27,850
-1,283
-4% -$276K 0.84% 19
2026
Q1
$6.34M Sell
29,133
-376
-1% -$83.4K 0.82% 18
2025
Q4
$6.74M Sell
29,509
-614
-2% -$140K 0.88% 18
2025
Q3
$6.97M Buy
30,123
+6,856
+29% +$1.4M 0.97% 17
2025
Q2
$4.32M Buy
23,267
+23,028
+9,635% +$4.28M 0.64% 23
2025
Q1
$50.1K Buy
239
+39
+20% +$7.58K 0.01% 196
2024
Q4
$35.5K Hold
200
0.01% 213
2024
Q3
$39.5K Sell
200
-17
-8% -$3.17K 0.01% 205
2024
Q2
$37.2K Sell
217
-27
-11% -$4.47K 0.01% 188
2024
Q1
$44.4K Buy
244
+44
+22% +$7.58K 0.01% 183
2023
Q4
$31K Hold
200
0.01% 199
2023
Q3
$29.8K Hold
200
0.01% 178
2023
Q2
$26.9K Buy
+200
New +$29.3K 0.01% 169

Other funds holding ABBV

First Pacific Financial's ABBV Position: Q2 2026 in Review

First Pacific Financial reduced its AbbVie (ABBV) stake by 4.4% in Q2 2026, selling an estimated $276K and leaving 27,850 shares worth $7.01M. The position accounts for 0.84% of the portfolio, ranked #19.

First Pacific Financial first reported a position in ABBV in Q2 2023 and has held it in 13 quarters since. 4,209 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • First Pacific Financial held 27,850 shares of AbbVie worth $7.01M as of Q2 2026.
  • First Pacific Financial sold 1,283 AbbVie shares in Q2 2026, an estimated $276K.
  • AbbVie made up 0.84% of First Pacific Financial's portfolio in Q2 2026, its #19 holding.
  • First Pacific Financial first reported a position in AbbVie in Q2 2023 and has held it in 13 quarters since.
  • 4,209 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on First Pacific Financial's 13F filing for Q2 2026, filed 20 Jul 2026.